According to InfuSystem's latest financial reports the company has $0.13 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.16 M | -11.29% |
2021-12-31 | $0.18 M | -98.07% |
2020-12-31 | $9.64 M | 264.49% |
2019-12-31 | $2.64 M | -38.7% |
2018-12-31 | $4.31 M | 24.47% |
2017-12-31 | $3.46 M | 2.09% |
2016-12-31 | $3.39 M | 315.4% |
2015-12-31 | $0.81 M | 58.83% |
2014-12-31 | $0.51 M | -54.75% |
2013-12-31 | $1.13 M | -51.07% |
2012-12-31 | $2.32 M | 191.11% |
2011-12-31 | $0.79 M | -84.06% |
2010-12-31 | $5.01 M | -35.3% |
2009-12-31 | $7.75 M | -32.68% |
2008-12-31 | $11.51 M | 190.73% |
2007-12-31 | $3.96 M | -95.98% |
2006-12-31 | $98.57 M | 725275.28% |
2005-12-31 | $0.01 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() Premier PINC | $91.49 M | 68,178.36% | ๐บ๐ธ USA |
![]() DexCom DXCM | $3.63 B | 2,713,482.09% | ๐บ๐ธ USA |
![]() CorVel Corporation
CRVL | $86.59 M | 64,521.64% | ๐บ๐ธ USA |
![]() Biolase
BIOL | $6.93 M | 5,071.64% | ๐บ๐ธ USA |